Acquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomes.
Acquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomes. BMC Cancer. 2015 Jul 10; 15:514.